Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox


The highest incidence (more than 3/100,000) of meningococcal serogroup C meningitis was found in Ireland, Iceland, Malta, the United Kingdom, Denmark, the Netherlands, Scotland and Spain. One possible explanation could be the emergence of a new clone of group C infection that has spread through England and Wales, as well as some areas of Europe.

Countries of average incidence (1-3/100,000) include Belgium, Norway, Slovak Republic, Switzerland, Lithuania, Ukraine, Spain, Portugal, Austria, Czech Republic, Greece, Latvia and the European part of Russia.

Low incidence (less than 1/100,000) has been reported from Croatia, Finland, France, Sweden and other European countries. In Germany the incidence of meningococcal C infections seems to be stable over the recent years (79% of cases caused by type B, 21% by type C). The case fatality rate of the disease is about 10%. Careful surveillance of the epidemiology of meningococcal disease in Germany is mandatory.

According to data collected in 1999, the overall incidence in Europe is 1.8/100,000 inhabitants.

 » Printversion

  » find


Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
» read more

Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more

Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more

Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,